Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at ResistanceZhen Wang, Yi‐Long Wu, Xu‐Chao Zhang et al.|Journal of Thoracic Oncology|2017Cited by 220
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Shun Lü, Fatao Liu et al.|Clinical Cancer Research|2017Cited by 20